Camizestrant
Etcamah · Oral selective estrogen-receptor degrader (SERD)
2026 oral SERD switched in at ESR1-mutation emergence, given with a CDK4/6 inhibitor; no attributable renal lesion (creatinine rose less often than on the comparator) — the boxed warning is QTc, so electrolytes matter.